Theravance Biopharma revenue was $60.37 m in FY, 2018 which is a 292.4% year over year increase from the previous period.
Theravance Biopharma revenue breakdown by geographic segment: 18.4% from Europe, 81.6% from US and 0.0% from Other
|FY, 2017||FY, 2016||FY, 2018|
|Europe||1.11 m||15.21 m||11.12 m|
|Asia||5 k||4 k||14 k|
|US||14.27 m||33.18 m||49.24 m|
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.